Considering the relevant role of transglutaminase (TG)-2 in the formation of an efficient phagocyte portal in macrophages15, we verified whether changes in the expression of this protein may be responsible for the impaired efferocytosis of CAD MDMs. This evidence concerns the gene TGM2 and coronary artery disorder.